Contineum Therapeutics, Inc. (CTNM) Misses Q1 EPS by 20c

Contineum Therapeutics, Inc. (NASDAQ: CTNM) reported Q1 EPS of ($0.62), $0.20 worse than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Contineum Therapeutics, Inc. (CTNM) click here.

You May Also Be Interested In

• Tesla readies August launch of CyberCab - The Information
• Micron Technology (MU) call put ratio 1.4 calls to 1 put on 1.2M contracts as share price up 4%
• Canaccord Downgrades York Space Systems (YSS) to Hold, 'Supply chain and contract timing uncertainty'